Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Large-scale testing (Phase 3)Study completedNCT01159600
What this trial is testing

Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,504
Testing effectiveness (Phase 2)Study completedNCT01376557
What this trial is testing

Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 299
Testing effectiveness (Phase 2)Study completedNCT01096667
What this trial is testing

Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)

Who this might be right for
Diabetes Mellitus, Type 2Hypertension
Merck Sharp & Dohme LLC 194
Large-scale testing (Phase 3)Study completedNCT03242018
What this trial is testing

Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease Stage 4
Lexicon Pharmaceuticals 277
Large-scale testing (Phase 3)Looking for participantsNCT07659574
What this trial is testing

Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone（UNIGUIDE-1）

Who this might be right for
Type 2 Diabetes
The United Bio-Technology (Hengqin) Co., Ltd. 360
Large-scale testing (Phase 3)Active Not RecruitingNCT06297603
What this trial is testing

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 320
Testing effectiveness (Phase 2)Study completedNCT01217073
What this trial is testing

A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 685
Large-scale testing (Phase 3)Study completedNCT02284893
What this trial is testing

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 461
Testing effectiveness (Phase 2)Study completedNCT03467932
What this trial is testing

Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Oramed, Ltd. 373
Post-approval studies (Phase 4)Study completedNCT00279201
What this trial is testing

The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 2,091
Testing effectiveness (Phase 2)Study completedNCT00309608
What this trial is testing

Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 333
Large-scale testing (Phase 3)Study completedNCT01392677
What this trial is testing

Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea

Who this might be right for
Type 2 Diabetes MellitusHigh HbA1c LevelInadequate Glycaemic Control
AstraZeneca 311
Large-scale testing (Phase 3)Study completedNCT01095653
What this trial is testing

A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,179
Large-scale testing (Phase 3)Study completedNCT01368081
What this trial is testing

Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,162
Post-approval studies (Phase 4)Study completedNCT00786136
What this trial is testing

Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes

Who this might be right for
Diabetes MellitusChronic Kidney Disease
Shenyang Northern Hospital 2,998
Large-scale testing (Phase 3)Study completedNCT04634500
What this trial is testing

The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Daewoong Pharmaceutical Co. LTD. 200
Post-approval studies (Phase 4)Study completedNCT02459353
What this trial is testing

Effect of Dapagliflozin on Glycemic Variability

Who this might be right for
Type 2 Diabetes Mellitus
The Catholic University of Korea 86
Testing effectiveness (Phase 2)Looking for participantsNCT07109700
What this trial is testing

HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 216
Early research (Phase 1)Study completedNCT00704132
What this trial is testing

Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Merck Sharp & Dohme LLC 57